BeBetter Med, Inc. Class A

As of June 30, 2026, BeBetter Med, Inc. Class A carries a market capitalization of 14.39B, placing it among publicly traded companies globally. Its enterprise value stands at 12.91B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, BeBetter Med, Inc. Class A has 450.04M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, BeBetter Med, Inc. Class A maintains a current ratio of 26.78, meaning it holds 26.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.23, indicating conservative leverage, while an interest coverage ratio of -2,758.02 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. The company generates approximately - - in revenue per employee across its workforce of 133.75, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, BeBetter Med, Inc. Class A recorded 44,210.74 in income tax expense. The company reported a pretax loss of -181.52M and -181.57M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

These figures are as of the close on October 23, 2026. The 50-day moving average sits at 22.71, while the 200-day moving average is 33.09.

Over the twelve months ended June 30, 2026, BeBetter Med, Inc. Class A generated - - in revenue and converted that into -181.57M in net income, yielding earnings per share of -0.41. EBITDA reached -181.50M, while operating income came in at -191.07M.

As of June 30, 2026, BeBetter Med, Inc. Class A holds 1.48B in cash and equivalents against 3.73M in total debt, resulting in a net debt position of -1.14B. Total book value stands at 1.59B, with working capital of 1.48B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, BeBetter Med, Inc. Class A paid dividends of 0.00 per share. The dividend payout ratio of 0.00 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield is negative at -10.36, meaning BeBetter Med, Inc. Class A raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, BeBetter Med, Inc. Class A has an Altman Z-Score of 145.75, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.